About Technology Issues FAQ

Links

Official Page

B-cell receptor pathway inhibitors affect CD20 levels and impair antitumor activity of anti-CD20 monoclonal antibodies

B-cell receptor pathway inhibitors affect CD20 levels and impair antitumor activity of anti-CD20 monoclonal antibodies — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.